Jennifer A. Carver MBA — Chief Operating Officer at La Jolla Pharmaceutical Company

Ms. Jennifer A. Carver, MBA, has been the Chief Operating Officer of La Jolla Pharmaceutical Company since January 20, 2017. Ms. Carver served as Senior Vice President of Operations at La Jolla Pharmaceutical Co since January 22, 2016 until January 20, 2017 and served as its Vice President of Operations until January 22, 2016. Ms. Carver served as a Vice President of Business Development and Project Management at La Jolla Pharmaceutical Co. since February 2014. Ms. Carver has over 13 years of experience in the biotechnology industry with a focus on program and alliance management including leadership of project teams for two FDA-approved drugs. Ms. Carver served as Senior Project Manager at Spectrum Pharmaceuticals, Inc. where she served as the Project Manager for the recently approved anti-cancer agent Beleodaq. She held various roles at Allos Therapeutics, Inc., including project manager for the approved anti-cancer agent, Folotyn. Ms. Carver earned her B.S.N. And M.B.A. from University of Colorado.